Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01631851 · ClinicalTrials.gov registry record · NA
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01631851: Completed NA study, sponsored by Yale University.
NCT01631851 is a NA study that has completed, run by Yale University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01631851, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
In addition to the core symptoms, children and adolescents with Autism Spectrum Disorder (ASD) often exhibit disruptive behavior problems including irritability, tantrums, noncompliance, and aggression. This is a pilot study of Cognitive-Behavioral Therapy, also known as Anger Control Training, in adolescents with high-functioning ASD. CBT teaches children to recognize antecedents and consequences of problem behavior and to use emotion regulation and problem-solving skills to reduce irritability, aggression and noncompliance. This form of CBT has been well-studied in typically developing children with disruptive behavior and we are investigating if this treatment can be feasible and helpful, with appropriate modifications, for irritability and disruptive behavior in ASD.
Primary Outcome
Parent rating of irritability and disruptive behavior that has been often used in studies with children with ASD
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy (CBT) for Irritability
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-04-23 |
| Phase | NA |
What the finished NCT01631851 record still lists
NCT01631851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Cognitive-Behavioral Therapy (CBT) for Irritability is the first listed.
NCT01631851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01631851 about?
NCT01631851 is a clinical study titled "Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder". In addition to the core symptoms, children and adolescents with Autism Spectrum Disorder (ASD) often exhibit disruptive behavior problems including irritability, tantrums, noncompliance, and aggression. This is a pilot study of Cognitive-Behavioral Therapy, also known as Anger Control Training, in a...
What is the current status of trial NCT01631851?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2011-05. Estimated completion is 2013-04-23.
What interventions are being tested in trial NCT01631851?
The interventions under investigation include: Cognitive-Behavioral Therapy (CBT) for Irritability (BEHAVIORAL).
Who is sponsoring clinical trial NCT01631851?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01631851's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia